| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.773 | 0.023 | 0.773 | DNA directed DNA polymerase inhibitor | 0.773 0.023 DBMET02605 0.585 0.059 DBMET00782 | ||
| 0.7 | 0 | 0.7 | Purine nucleoside phosphorylase inhibitor | 0.7 0 DBMET02605 0.08 0.001 DBMET00782 | ||
| 0.656 | 0.003 | 0.656 | RNA-directed DNA polymerase inhibitor | 0.656 0.003 DBMET02605 0.604 0.005 DBMET00782 | ||
| 0.65 | 0.001 | 0.65 | Thymidine kinase inhibitor | 0.65 0.001 DBMET02605 0.182 0.003 DBMET00782 | ||
| 0.61 | 0.007 | 0.61 | DNA synthesis inhibitor | 0.61 0.007 DBMET02605 0.472 0.015 DBMET00782 | ||
| 0.598 | 0.012 | 0.598 | Immunomodulator | 0.598 0.012 DBMET02605 0.304 0.08 DBMET00782 | ||
| 0.561 | 0.003 | 0.561 | DNA polymerase I inhibitor | 0.561 0.003 DBMET02605 0.532 0.003 DBMET00782 | ||
| 0.415 | 0.001 | 0.415 | Adenosine deaminase inhibitor | 0.415 0.001 DBMET02605 0.162 0.003 DBMET00782 | ||
| 0.414 | 0.058 | 0.414 | Immunosuppressant | 0.414 0.058 DBMET02605 0.231 0.165 DBMET00782 | ||
| 0.332 | 0.006 | 0.332 | DNA directed RNA polymerase inhibitor | 0.332 0.006 DBMET02605 0.201 0.014 DBMET00782 | ||
| 0.363 | 0.06 | 0.363 | Immunostimulant | 0.363 0.06 DBMET02605 0.324 0.072 DBMET00782 | ||
| 0.279 | 0.006 | 0.279 | HIV-1 reverse transcriptase inhibitor | 0.279 0.006 DBMET02605 0.167 0.012 DBMET00782 | ||
| 0.281 | 0.013 | 0.281 | Interleukin 1 antagonist | 0.281 0.013 DBMET02605 0.25 0.019 DBMET00782 | ||
| 0.26 | 0.006 | 0.26 | Antimetabolite | 0.26 0.006 DBMET02605 0.216 0.009 DBMET00782 | ||
| 0.326 | 0.084 | 0.333 | Vasodilator, peripheral | 0.326 0.084 DBMET02605 0.333 0.081 DBMET00782 | DBMET00782 | |
| 0.24 | 0.005 | 0.24 | Folate antagonist | 0.24 0.005 DBMET02605 0.112 0.046 DBMET00782 | ||
| 0.25 | 0.023 | 0.25 | Interleukin 6 antagonist | 0.25 0.023 DBMET02605 0.185 0.051 DBMET00782 | ||
| 0.216 | 0 | 0.216 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.216 0 DBMET02605 0.138 0.001 DBMET00782 | ||
| 0.321 | 0.113 | 0.321 | Histamine release inhibitor | 0.321 0.113 DBMET02605 | ||
| 0.191 | 0.007 | 0.191 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.191 0.007 DBMET02605 0.116 0.012 DBMET00782 | ||
| 0.191 | 0.009 | 0.191 | CDK1/cyclin B1 inhibitor | 0.191 0.009 DBMET02605 0.066 0.052 DBMET00782 | ||
| 0.207 | 0.026 | 0.207 | MAP kinase kinase 5 inhibitor | 0.207 0.026 DBMET02605 0.158 0.122 DBMET00782 | ||
| 0.2 | 0.026 | 0.2 | Alkylator | 0.2 0.026 DBMET02605 0.098 0.091 DBMET00782 | ||
| 0.181 | 0.01 | 0.181 | CDK1/cyclin B inhibitor | 0.181 0.01 DBMET02605 | ||
| 0.227 | 0.071 | 0.227 | Interleukin antagonist | 0.227 0.071 DBMET02605 0.202 0.083 DBMET00782 | ||
| 0.168 | 0.019 | 0.168 | DNA repair enzyme inhibitor | 0.168 0.019 DBMET02605 | ||
| 0.151 | 0.002 | 0.151 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.151 0.002 DBMET02605 0.042 0.005 DBMET00782 | ||
| 0.206 | 0.079 | 0.206 | Nitric-oxide synthase stimulant | 0.206 0.079 DBMET02605 | ||
| 0.164 | 0.037 | 0.164 | Adenylate cyclase inhibitor | 0.164 0.037 DBMET02605 | ||
| 0.145 | 0.018 | 0.145 | MAP kinase kinase 1 inhibitor | 0.145 0.018 DBMET02605 | ||
| 0.153 | 0.033 | 0.168 | Xanthine oxidase inhibitor | 0.153 0.033 DBMET02605 0.168 0.028 DBMET00782 | DBMET00782 | |
| 0.136 | 0.017 | 0.136 | Cyclin B3 inhibitor | 0.136 0.017 DBMET02605 | ||
| 0.138 | 0.021 | 0.138 | NADH dehydrogenase inhibitor | 0.138 0.021 DBMET02605 0.103 0.041 DBMET00782 | ||
| 0.146 | 0.045 | 0.15 | Death-associated protein kinase 1 inhibitor | 0.146 0.045 DBMET02605 0.15 0.04 DBMET00782 | DBMET00782 | |
| 0.114 | 0.017 | 0.114 | Carbamoyl phosphate synthetase inhibitor | 0.114 0.017 DBMET02605 0.086 0.026 DBMET00782 | ||
| 0.156 | 0.059 | 0.156 | MAP kinase 3 inhibitor | 0.156 0.059 DBMET02605 | ||
| 0.133 | 0.04 | 0.133 | CDK3/cyclin E inhibitor | 0.133 0.04 DBMET02605 | ||
| 0.281 | 0.188 | 0.281 | 5 Hydroxytryptamine release inhibitor | 0.281 0.188 DBMET02605 | ||
| 0.123 | 0.035 | 0.123 | Phosphodiesterase 7B inhibitor | 0.123 0.035 DBMET02605 | ||
| 0.128 | 0.04 | 0.128 | Bronchodilator | 0.128 0.04 DBMET02605 | ||
| 0.135 | 0.048 | 0.135 | Cyclin-dependent kinase 1 inhibitor | 0.135 0.048 DBMET02605 | ||
| 0.085 | 0.001 | 0.085 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.085 0.001 DBMET02605 0.043 0.002 DBMET00782 | ||
| 0.111 | 0.028 | 0.111 | Phosphofructokinase-1 inhibitor | 0.111 0.028 DBMET02605 0.083 0.039 DBMET00782 | ||
| 0.088 | 0.005 | 0.088 | Thymidylate synthase inhibitor | 0.088 0.005 DBMET02605 0.063 0.015 DBMET00782 | ||
| 0.108 | 0.025 | 0.108 | Adenosine A2 receptor antagonist | 0.108 0.025 DBMET02605 | ||
| 0.081 | 0.004 | 0.081 | Phosphodiesterase 6B inhibitor | 0.081 0.004 DBMET02605 0.077 0.004 DBMET00782 | ||
| 0.099 | 0.023 | 0.099 | Adenosine A1 receptor antagonist | 0.099 0.023 DBMET02605 | ||
| 0.075 | 0.004 | 0.075 | Phosphodiesterase 6C inhibitor | 0.075 0.004 DBMET02605 0.073 0.004 DBMET00782 | ||
| 0.087 | 0.016 | 0.087 | Cyclin B1 inhibitor | 0.087 0.016 DBMET02605 | ||
| 0.124 | 0.053 | 0.124 | GABA receptor agonist | 0.124 0.053 DBMET02605 | ||
| 0.097 | 0.027 | 0.097 | Phenylalanine 4-hydroxylase inhibitor | 0.097 0.027 DBMET02605 | ||
| 0.133 | 0.063 | 0.133 | MAP kinase kinase inhibitor | 0.133 0.063 DBMET02605 | ||
| 0.081 | 0.014 | 0.081 | Cyclin B2 inhibitor | 0.081 0.014 DBMET02605 | ||
| 0.097 | 0.031 | 0.097 | Interferon agonist | 0.097 0.031 DBMET02605 | ||
| 0.081 | 0.021 | 0.081 | Ornithine carbamoyltransferase inhibitor | 0.081 0.021 DBMET02605 0.052 0.038 DBMET00782 | ||
| 0.082 | 0.022 | 0.082 | Interferon inducer | 0.082 0.022 DBMET02605 | ||
| 0.113 | 0.054 | 0.113 | Check point kinase 2 inhibitor | 0.113 0.054 DBMET02605 | ||
| 0.076 | 0.018 | 0.076 | Cyclin B inhibitor | 0.076 0.018 DBMET02605 | ||
| 0.111 | 0.061 | 0.132 | Nav1.4 sodium channel blocker | 0.111 0.061 DBMET02605 0.132 0.043 DBMET00782 | DBMET00782 | |
| 0.065 | 0.018 | 0.065 | Phosphodiesterase 3B inhibitor | 0.065 0.018 DBMET02605 | ||
| 0.092 | 0.045 | 0.092 | Hematopoietic | 0.092 0.045 DBMET02605 | ||
| 0.058 | 0.012 | 0.058 | Dihydropteroate synthase inhibitor | 0.058 0.012 DBMET02605 | ||
| 0.084 | 0.041 | 0.084 | Glutamate dehydrogenase inhibitor | 0.084 0.041 DBMET02605 | ||
| 0.093 | 0.054 | 0.093 | Phosphodiesterase I inhibitor | 0.093 0.054 DBMET02605 | ||
| 0.042 | 0.004 | 0.042 | Phosphodiesterase 6H inhibitor | 0.042 0.004 DBMET02605 0.041 0.004 DBMET00782 | ||
| 0.042 | 0.004 | 0.042 | Phosphodiesterase 6G inhibitor | 0.042 0.004 DBMET02605 0.041 0.004 DBMET00782 | ||
| 0.068 | 0.031 | 0.068 | Argininosuccinate synthase inhibitor | 0.068 0.031 DBMET02605 0.051 0.046 DBMET00782 | ||
| 0.078 | 0.043 | 0.078 | Phosphodiesterase V inhibitor | 0.078 0.043 DBMET02605 0.064 0.059 DBMET00782 | ||
| 0.069 | 0.037 | 0.069 | Neuraminidase (influenza) inhibitor | 0.069 0.037 DBMET02605 | ||
| 0.157 | 0.127 | 0.157 | Growth factor agonist | 0.157 0.127 DBMET02605 | ||
| 0.05 | 0.02 | 0.05 | Nicotinic acid receptor 1 agonist | 0.05 0.02 DBMET02605 | ||
| 0.041 | 0.011 | 0.041 | Uridine phosphorylase inhibitor | 0.041 0.011 DBMET02605 | ||
| 0.034 | 0.005 | 0.034 | Phosphodiesterase 6A inhibitor | 0.034 0.005 DBMET02605 0.03 0.007 DBMET00782 | ||
| 0.099 | 0.07 | 0.099 | Adenylate kinase inhibitor | 0.099 0.07 DBMET02605 0.094 0.078 DBMET00782 | ||
| 0.05 | 0.023 | 0.05 | AICAR transformylase inhibitor | 0.05 0.023 DBMET02605 0.041 0.035 DBMET00782 | ||
| 0.035 | 0.008 | 0.037 | DNA polymerase III inhibitor | 0.035 0.008 DBMET02605 0.037 0.006 DBMET00782 | DBMET00782 | |
| 0.107 | 0.081 | 0.107 | Interleukin 8 antagonist | 0.107 0.081 DBMET02605 | ||
| 0.215 | 0.189 | 0.215 | GABA C receptor rho-3 antagonist | 0.215 0.189 DBMET02605 | ||
| 0.043 | 0.017 | 0.043 | Phosphoglycerate kinase inhibitor | 0.043 0.017 DBMET02605 | ||
| 0.04 | 0.016 | 0.04 | Purinergic P2X3 antagonist | 0.04 0.016 DBMET02605 | ||
| 0.077 | 0.056 | 0.077 | MAP kinase kinase 7 inhibitor | 0.077 0.056 DBMET02605 | ||
| 0.061 | 0.04 | 0.061 | Biliverdin reductase inhibitor | 0.061 0.04 DBMET02605 | ||
| 0.037 | 0.019 | 0.037 | Purinergic P2Y2 antagonist | 0.037 0.019 DBMET02605 0.031 0.028 DBMET00782 | ||
| 0.081 | 0.065 | 0.081 | mTOR complex 2 inhibitor | 0.081 0.065 DBMET02605 | ||
| 0.082 | 0.066 | 0.082 | CDK/cyclin complex inhibitor | 0.082 0.066 DBMET02605 | ||
| 0.048 | 0.036 | 0.048 | Adenosine A2b receptor antagonist | 0.048 0.036 DBMET02605 | ||
| 0.158 | 0.147 | 0.158 | Tumour necrosis factor alpha release inhibitor | 0.158 0.147 DBMET02605 | ||
| 0.066 | 0.055 | 0.066 | Phosphodiesterase 5A inhibitor | 0.066 0.055 DBMET02605 | ||
| 0.01 | 0.003 | 0.016 | DNA polymerase III subunit alpha inhibitor | 0.01 0.003 DBMET02605 0.016 0.002 DBMET00782 | DBMET00782 | |
| 0.01 | 0.004 | 0.01 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.01 0.004 DBMET02605 0.007 0.006 DBMET00782 | ||
| 0.087 | 0.08 | 0.087 | Interleukin 12 antagonist | 0.087 0.08 DBMET02605 | ||
| 0.047 | 0.042 | 0.047 | Factor IXa inhibitor | 0.047 0.042 DBMET02605 | ||
| 0.188 | 0.184 | 0.188 | Angiogenesis inhibitor | 0.188 0.184 DBMET02605 | ||
| 0.019 | 0.018 | 0.019 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.019 0.018 DBMET02605 | ||
| 0.113 | 0.114 | 0.151 | Diuretic | 0.151 0.076 DBMET00782 | DBMET00782 | |
| 0.077 | 0.1 | 0.104 | GABA C receptor agonist | 0.104 0.062 DBMET00782 | DBMET00782 | |
| 0.13 | 0.255 | 0.238 | Hypoxia-inducible factor 1 alpha inhibitor | 0.238 0.112 DBMET00782 | DBMET00782 | |
| 0.079 | 0.306 | 0.141 | Succinate dehydrogenase inhibitor | 0.141 0.131 DBMET00782 | DBMET00782 | |
| 0.005 | 0.389 | 0.031 | Prostacyclin antagonist | 0.031 0.025 DBMET00782 | DBMET00782 | |
| 0.023 | 0.568 | 0.161 | Platelet aggregation inhibitor | 0.161 0.116 DBMET00782 | DBMET00782 | |
| 0.002 | 0.727 | 0.03 | Prostacyclin agonist | 0.03 0.006 DBMET00782 | DBMET00782 | |
| 0.005 | 0.815 | 0.241 | Platelet antagonist | 0.241 0.077 DBMET00782 | DBMET00782 | |
| 0.002 | 0.848 | 0.038 | Prostaglandin D2 agonist | 0.038 0.014 DBMET00782 | DBMET00782 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |